211 related articles for article (PubMed ID: 1570319)
1. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs.
Zambetti GP; Olson D; Labow M; Levine AJ
Proc Natl Acad Sci U S A; 1992 May; 89(9):3952-6. PubMed ID: 1570319
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
Kikuchi-Yanoshita R; Tanaka K; Muraoka M; Konishi M; Kawashima I; Takamoto S; Hirai H; Miyaki M
Oncogene; 1995 Oct; 11(7):1339-45. PubMed ID: 7478555
[TBL] [Abstract][Full Text] [Related]
3. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
Hinds PW; Finlay CA; Quartin RS; Baker SJ; Fearon ER; Vogelstein B; Levine AJ
Cell Growth Differ; 1990 Dec; 1(12):571-80. PubMed ID: 2288874
[TBL] [Abstract][Full Text] [Related]
5. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
Hinds P; Finlay C; Levine AJ
J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
[TBL] [Abstract][Full Text] [Related]
6. The properties of p53 proteins selected for the loss of suppression of transformation.
Olson DC; Levine AJ
Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest.
Hicks GG; Egan SE; Greenberg AH; Mowat M
Mol Cell Biol; 1991 Mar; 11(3):1344-52. PubMed ID: 1996096
[TBL] [Abstract][Full Text] [Related]
8. The p53 proto-oncogene can act as a suppressor of transformation.
Finlay CA; Hinds PW; Levine AJ
Cell; 1989 Jun; 57(7):1083-93. PubMed ID: 2525423
[TBL] [Abstract][Full Text] [Related]
9. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
10. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization is essential for the activity of p53 protein.
Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
[TBL] [Abstract][Full Text] [Related]
12. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
[TBL] [Abstract][Full Text] [Related]
13. Neoplastic transformation of normal rat embryo fibroblasts by a mutated p53 and an activated ras oncogene induces parathyroid hormone-related peptide gene expression and causes hypercalcemia in nude mice.
Motokura T; Endo K; Kumaki K; Ogata E; Ikeda K
J Biol Chem; 1995 Dec; 270(52):30857-61. PubMed ID: 8537338
[TBL] [Abstract][Full Text] [Related]
14. Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression.
Burns JS; Blaydes JP; Wright PA; Lemoine L; Bond JA; Williams ED; Wynford-Thomas D
Mol Carcinog; 1992; 6(2):129-39. PubMed ID: 1388684
[TBL] [Abstract][Full Text] [Related]
15. p53 mutations and tetraploids under r- and K-selection.
Chikatsu N; Nakamura Y; Sato H; Fujita T; Asano S; Motokura T
Oncogene; 2002 May; 21(19):3043-9. PubMed ID: 12082535
[TBL] [Abstract][Full Text] [Related]
16. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras.
Bristow RG; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
Oncogene; 1994 Jun; 9(6):1527-36. PubMed ID: 8183546
[TBL] [Abstract][Full Text] [Related]
18. [The protective role of p53 in Ras-induced transformation of REF52 cells].
Kopnin PB; Ivanov AV; Il'inskaia GV; Sablina AA; Kopnin BP; Chumakov PM
Mol Biol (Mosk); 2003; 37(3):458-71. PubMed ID: 12815953
[TBL] [Abstract][Full Text] [Related]
19. Mutation of the endogenous p53 gene in cells transformed by HPV-16 E7 and EJ c-ras confers a growth advantage involving an autocrine mechanism.
Peacock JW; Benchimol S
EMBO J; 1994 Mar; 13(5):1084-92. PubMed ID: 8131742
[TBL] [Abstract][Full Text] [Related]
20. Reduced levels of alpha 1 (I) collagen mRNA in cells immortalized by mutant p53 or transformed by ras.
Eizenberg O; Oren M
Biochim Biophys Acta; 1991 Dec; 1129(1):34-42. PubMed ID: 1756178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
